By Topic

Effect of atorvastatin combined with coenzyme Q10 on uncoupling protein 2 gene expression in rats with heart failure after myocardial infarction

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Zhao Dongming ; Dept. of Cardiology, Beihua Univ., Jilin, China ; Yang Ping

Objectiv to study the anti-oxidation effects of atorvastatin and coenzyme Q10 on heart failure in rats. Methods: After ligating their left anterior descending coronary artery and feeding for 6 weeks, 24 survived rats were randomly divided into sham group (n=6), model group (n=6), atorvastatin group (n=6) and atorvastatin + coenzyme Q10 group (n=6). Following continuous intragastric administration for 5 weeks, hemodynamic parameters, heart weight/body weight (HW/BW), left ventricular heart weight/body weight (LVHW/BW), serum superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were measured for rats. UCP2 mRNA expression levels were determined by RT-PCR in non-infarcted myocardium. Results: Atorvastatin combined with coenzyme Q10 can significantly increase ±dp/dtmax and SOD activity, and reduce left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), cardiac hypertrophy index, serum MDA levels and UCP2 mRNA expression levels (P<;0.05~0.001), but had no significant effect on heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) (P>;0.05). Conclusion: Atorvastatin combined with coenzyme Q10 can down-regulate UCP2 mRNA expression levels in myocardial cells for rats with heart failure after myocardial infarction and improve energy metabolism in ventricular remodeling of heart failure via anti-oxidation effects.

Published in:

Human Health and Biomedical Engineering (HHBE), 2011 International Conference on

Date of Conference:

19-22 Aug. 2011